BridgeMD
New treatment option for Labor Pain
Official title Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management During Labor.
ClinicalTrials.gov ID: NCT07401147
What this study is testing
- What it's testing
- This is a randomized, double-blind, crossover clinical trial to evaluate the efficacy of transcutaneous electrical nerve stimulation (TENS) as a non-pharmacological therapeutic intervention for reducing pain in women during the active phase of labor. Nulliparous women with term pregnancies will be randomly assigned to sequences involving TENS intervention and placebo (device off) periods, separated by a washout.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, women only. Healthy volunteers may be eligible.
You may be able to join if
- Signed informed consent.
- Women aged 18-45 years.
- Nulliparous.
- Term singleton pregnancy (37-42 weeks).
- Cephalic presentation.
You likely can't join if
- Multiple pregnancy.
- Non-cephalic presentation.
- Severe obstetric complications (e.g., preeclampsia, placental abruption).
- Maternal chronic or acute diseases interfering with safety.
- History of neurological/psychiatric disorders contraindicating TENS.
- Abnormal fetal monitoring or amniotic fluid.
See the full eligibility criteria
- Signed informed consent.
- Women aged 18-45 years.
- Nulliparous.
- Term singleton pregnancy (37-42 weeks).
- Cephalic presentation.
- Spontaneous onset of labor or induced/conducted labor under adequate control.
- Cervical dilation of at least 5 cm at enrollment.
- Normal amniotic fluid volume and reassuring fetal monitoring.
- Uncomplicated pregnancy.
- Multiple pregnancy.
- Non-cephalic presentation.
- Severe obstetric complications (e.g., preeclampsia, placental abruption).
- Maternal chronic or acute diseases interfering with safety.
- History of neurological/psychiatric disorders contraindicating TENS.
- Abnormal fetal monitoring or amniotic fluid.
- Pre-pregnancy BMI \>30 kg/m².
- Fetal demise.
- Illiteracy.
The study team makes the final eligibility decision.
Where it's taking place
- Tegucigalpa, Francisco Morazán Department, Honduras
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 45 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tegucigalpa, Francisco Morazán Department, Honduras. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.